Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Alonso Carrión

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 3, 2009
Phase II study of weekly Kahalalide F in patients with advanced malignant melanomaSalvador Martín-Algarra, Enrique Espinosa, Jordi Rubió, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2010
Cisplatin-based radiochemotherapy improves the negative prognosis of c-erbB-2 overexpressing advanced cervical cancerJosé Pérez-Regadera, Alfonso Sánchez-Muñoz, Javier De-la-Cruz, et al.
Oncology|November 17, 2010
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancerAlfonso Sánchez-Muñoz, César Mendiola, Elisabeth Pérez-Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)José María Piulats, Enrique Espinosa, Luis de la Cruz Merino, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|February 3, 2009
Phase II study of weekly Kahalalide F in patients with advanced malignant melanomaSalvador Martín-Algarra, Enrique Espinosa, Jordi Rubió, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2010
Cisplatin-based radiochemotherapy improves the negative prognosis of c-erbB-2 overexpressing advanced cervical cancerJosé Pérez-Regadera, Alfonso Sánchez-Muñoz, Javier De-la-Cruz, et al.
Oncology|November 17, 2010
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancerAlfonso Sánchez-Muñoz, César Mendiola, Elisabeth Pérez-Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)José María Piulats, Enrique Espinosa, Luis de la Cruz Merino, et al.
Pageof 1